Meegdes, Marissa http://orcid.org/0000-0002-7739-260X
Ibragimova, Khava I. E.
Lobbezoo, Dorien J. A.
Vriens, Ingeborg J. H.
Kooreman, Loes F. S.
Erdkamp, Frans L. G.
Dercksen, M. Wouter
Vriens, Birgit E. P. J.
Aaldering, Kirsten N. A.
Pepels, Manon J. A. E.
van de Winkel, Linda M. H.
Tol, Jolien
Heijns, Joan B.
van de Wouw, Agnes J.
Peters, Natascha A. J. B.
Hochstenbach-Waelen, Ananda
Smidt, Marjolein L.
Geurts, Sandra M. E.
Tjan-Heijnen, Vivianne C. G.
Funding for this research was provided by:
ZonMw (ZonMw: 80-82500-98-8003)
Novartis
Roche
Pfizer Pharmaceuticals
Eli Lilly and Company
Article History
Received: 12 October 2021
Accepted: 1 December 2021
First Online: 13 January 2022
Declarations
:
: MM, KI, and AHW report grant of the Netherlands Organization for Health Research and Development (ZonMw: 80–82500-98–8003) and financial support by Novartis BV, Roche, Pfizer, and Eli Lilly, as listed in the funding section. IV reports grant from Pfizer. SG reports institutional grants from Novartis BV, Roche, Pfizer, Eli Lilly, and Daiichi Sankyo and personal fees from AstraZeneca. VTH reports grants and personal fees from Roche, grants and personal fees from Novartis, grants and personal fees from Pfizer, grants and personal fees from Lilly, personal fees from Accord Healthcare, grants from AstraZeneca, grants from Eisai, and grants from Daiichi Sankyo. All remaining authors have declared no conflict of interest.
: The SONABRE Registry (NCT-03577197) was approved and the need for informed consent waived by the Medical Research Ethics Committee of Maastricht University Medical Center (METC 15-4-239).